SCHEMBL12419405

SCHEMBL12419405

Cc1cc(B(O)O)cnc1N1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 2/20 0.43
NPC1 O15118 1/20 0.40
PKM P14618 1/20 0.40
ALDH1A1 P00352 3/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
JAK2 O60674 1/20 0.36
MAPT P10636 4/20 0.36
TP53 P04637 4/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 2/20 0.36
KDM4E B2RXH2 2/20 0.36
HPGD P15428 1/20 0.36
RECQL P46063 1/20 0.36
HSD17B10 Q99714 1/20 0.36
SCN10A Q9Y5Y9 1/20 0.35
CNR2 P34972 1/20 0.35
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25184755 0.86 ALDH1A1 (0.40) PKMALDH1A1MAPTTP53SMN1; SMN2
SCHEMBL30376783 0.86 ALDH1A1 (0.40) PKMALDH1A1MAPTTP53SMN1; SMN2
SCHEMBL1708576 0.84 ALDH1A1 (0.40) ALDH1A1MAPK1MAPTTP53LMNA
SCHEMBL29953774 0.84 ALDH1A1 (0.40) DHODHNPC1PKMALDH1A1MAPK1
Hydrochloric Acid SCHEMBL29951158 0.83 ALDH1A1 (0.40) ALDH1A1MAPK1MAPTTP53LMNA
SCHEMBL16945095 0.78 CNR2 (0.53) DHODHNPC1PKMALDH1A1MAPK1
SCHEMBL25930955 0.76 KDM4E (0.38) NPC1ALDH1A1MAPK1HTTMAPT
SCHEMBL12991619 0.75 CNR2 (0.50) DHODHNPC1PKMALDH1A1MAPK1
SCHEMBL20606424 0.75 CNR2 (0.47) NPC1PKMALDH1A1MAPK1MAPT
SCHEMBL25929004 0.75 MTOR (0.34) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2015-12-24 US disclosed
US-8957049-B2 Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS, INC. (US) 2015-02-17 US disclosed
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 DHODH 402/4885NPC1 472/4885PKM 3022/4885
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 DHODH 402/4885NPC1 472/4885PKM 3022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.